You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

demethylation drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid Trial in Guanzhou (Decitabine and Ara-C, Ara-C)

Recruiting
  • Leukemia, Myeloid
  • Guanzhou, Guangdong, China
    Nanfang Hospital of Southern Medical University
Apr 24, 2020

MDS Trial (Yisui granule, Placebo)

Not yet recruiting
  • MDS
  • Yisui granule
  • Placebo
  • (no location specified)
Jan 13, 2023

Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

Recruiting
  • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
  • TQB2618 injection azacitidine, AZA decitabine, DAC
  • ChengDu, Sichuan, China
    West China Hospital of Sichuan University
Jun 16, 2022

Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)

Not yet recruiting
  • Acute Kidney Disease
  • Taipei City, Taiwan
    Yu Hsiang Chou
May 2, 2022

Tinea Versicolor Trial in Abbottabad (Fluconazole, Itraconazole)

Completed
  • Tinea Versicolor
  • Abbottābād, Khyber Pakhtunkhwa, Pakistan
    CMH Abbottabad
May 8, 2023

T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Oral Azacitidine)

Recruiting
  • T-Cell Large Granular Lymphocyte Leukemia
  • Oral Azacitidine
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Hiatus Hernia in Gastro-Esophageal Reflux Disease Patients

Not yet recruiting
  • Hiatus Hernia
  • Upper Endoscopy
  • (no location specified)
Nov 24, 2023

Malignancy Trial in Shenzhen (Decitabine combined with NK cell infusion)

Recruiting
  • Malignancy
  • Decitabine combined with NK cell infusion
  • Shenzhen, Guangdong, China
    Shenzhen University General hospital
Nov 22, 2021

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Pediatric Surgical Patient Trial in Boston (oral oxycodone)

Recruiting
  • Pediatric Surgical Patient
  • oral oxycodone
  • Boston, Massachusetts
    Boston Children Hospital
Jun 6, 2022

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • NanJing, China
    Department of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022

Head and Neck Squamous Cell Carcinoma Trial in New Haven (5-Azacitadine)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • New Haven, Connecticut
    Smilow Cancer Center at Yale New Haven Hospital
Feb 3, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Dec 7, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
Feb 17, 2022

Premature Birth Trial in Milan (Early Intervention)

Active, not recruiting
  • Premature Birth
  • Early Intervention
  • Milan, Italy
    NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Feb 2, 2023

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023

Malignant Tumor Trial in Shenzhen (DC-CTL)

Recruiting
  • Malignant Tumor
  • DC-CTL
  • Shenzhen, Guangdong, China
    Shenzhen University General Hospital
Dec 16, 2020

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial in Duarte (Nivolumab, Oral Azacitidine)

Recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Nivolumab
  • Oral Azacitidine
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Azacitidine Injection
  • Houston, Texas
    Harris Health System - Ben Taub Hospital
Sep 1, 2022